Search research articles
Contact Us
Filters
Showing results (81-90 of 171) with videos related to
Page
of 18
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 12, 2014
Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP)
Richard Haynes, Natalie Staplin, Jonathan Emberson, et al.
BMC Nephrology
|
May 1, 2015
What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
Seamus Kent, Iryna Schlackow, Jingky Lozano-Kühne, et al.
Pharmacoeconomics
|
February 24, 2023
Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK
Junwen Zhou, Runguo Wu, Claire Williams, et al.
Lancet (London, England)
|
June 2, 2009
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
, Colin Baigent, Lisa Blackwell, et al.
Health Technology Assessment (Winchester, England)
|
December 7, 2024
Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data sets
Borislava Mihaylova, Runguo Wu, Junwen Zhou, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
September 23, 2016
Effect of Processing Delay and Storage Conditions on Urine Albumin-to-Creatinine Ratio
William Herrington, Nicola Illingworth, Natalie Staplin, et al.
The Lancet Regional Health. Europe
|
March 29, 2024
Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling study
Borislava Mihaylova, Runguo Wu, Junwen Zhou, et al.
Heart (British Cardiac Society)
|
September 10, 2024
Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study
Borislava Mihaylova, Runguo Wu, Junwen Zhou, et al.
The New England Journal of Medicine
|
November 13, 2009
Revascularization versus medical therapy for renal-artery stenosis
, Keith Wheatley, Natalie Ives, et al.
Clinical Kidney Journal
|
September 9, 2020
Erratum: The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study
William G Herrington, David Preiss, Richard Haynes, et al.
Page
of 18
Search research articles
Search
Showing results (81-90 of 171) with videos related to
Sort By:
Page
of 18
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 12, 2014
Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP)
Richard Haynes, Natalie Staplin, Jonathan Emberson, et al.
BMC Nephrology
|
May 1, 2015
What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
Seamus Kent, Iryna Schlackow, Jingky Lozano-Kühne, et al.
Pharmacoeconomics
|
February 24, 2023
Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK
Junwen Zhou, Runguo Wu, Claire Williams, et al.
Lancet (London, England)
|
June 2, 2009
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
, Colin Baigent, Lisa Blackwell, et al.
Health Technology Assessment (Winchester, England)
|
December 7, 2024
Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data sets
Borislava Mihaylova, Runguo Wu, Junwen Zhou, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
September 23, 2016
Effect of Processing Delay and Storage Conditions on Urine Albumin-to-Creatinine Ratio
William Herrington, Nicola Illingworth, Natalie Staplin, et al.
The Lancet Regional Health. Europe
|
March 29, 2024
Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling study
Borislava Mihaylova, Runguo Wu, Junwen Zhou, et al.
Heart (British Cardiac Society)
|
September 10, 2024
Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study
Borislava Mihaylova, Runguo Wu, Junwen Zhou, et al.
The New England Journal of Medicine
|
November 13, 2009
Revascularization versus medical therapy for renal-artery stenosis
, Keith Wheatley, Natalie Ives, et al.
Clinical Kidney Journal
|
September 9, 2020
Erratum: The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study
William G Herrington, David Preiss, Richard Haynes, et al.
Page
of 18